Management of Direct Oral Anticoagulants in Atrial Fibrillation After Cerebrovascular Accident with Infarct and History of Intracranial Bleeding

Introduction to DOAC Management

The European Society of Cardiology recommends that DOACs can be cautiously restarted 10-14 days after an ischemic stroke with infarct in AF patients, but a prior history of spontaneous intracranial hemorrhage constitutes a contraindication to anticoagulation unless the underlying cause has been definitively reversed 1

The American College of Cardiology recommends initiating oral anticoagulation when considered safe from hemorrhagic transformation perspective, typically between 2 and 14 days following an acute ischemic event 2, 3
Anticoagulation is contraindicated according to both DOAC labeling and VKA guidelines unless the cause of prior spontaneous intracranial hemorrhage has been reversed 1

The European Society of Cardiology recommends DOACs in preference to VKAs for all eligible AF patients except those with mechanical heart valves or moderate-to-severe mitral stenosis 4
DOACs demonstrate a 50% reduction in intracranial hemorrhage risk compared to warfarin 4

The European Society of Cardiology recommends assessing renal function before initiating any DOAC, as DOACs are contraindicated in severe renal impairment 4
The American College of Cardiology advises against adding antiplatelet therapy to anticoagulation for stroke prevention in AF, as this increases bleeding without reducing thromboembolism 2, 3, 4
Interrupting anticoagulation is mandatory if active bleeding occurs until the cause is identified and resolved 4